PMC:7405836 / 94632-95009 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T332","span":{"begin":25,"end":29},"obj":"Body_part"},{"id":"T333","span":{"begin":64,"end":67},"obj":"Body_part"},{"id":"T334","span":{"begin":220,"end":223},"obj":"Body_part"}],"attributes":[{"id":"A332","pred":"fma_id","subj":"T332","obj":"http://purl.org/sig/ont/fma/fma67122"},{"id":"A333","pred":"fma_id","subj":"T333","obj":"http://purl.org/sig/ont/fma/fma74412"},{"id":"A334","pred":"fma_id","subj":"T334","obj":"http://purl.org/sig/ont/fma/fma67095"}],"text":"Vaccine candidates, like mRNA-1273 SARS-CoV-2 vaccine, INO-4800 DNA coronavirus vaccine, and adenovirus type 5 vector vaccine candidate (Ad5-nCoV), are a few examples under phase I clinical trials, while self-amplifying RNA vaccine, oral recombinant COVID-19 vaccine, BNT162, plant-based COVID-19 vaccine, and Ii-Key peptide COVID-19 vaccine are under preclinical trials (297)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T876","span":{"begin":35,"end":43},"obj":"Disease"},{"id":"T877","span":{"begin":35,"end":39},"obj":"Disease"},{"id":"T878","span":{"begin":137,"end":140},"obj":"Disease"},{"id":"T879","span":{"begin":250,"end":258},"obj":"Disease"},{"id":"T880","span":{"begin":288,"end":296},"obj":"Disease"},{"id":"T881","span":{"begin":325,"end":333},"obj":"Disease"}],"attributes":[{"id":"A876","pred":"mondo_id","subj":"T876","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A877","pred":"mondo_id","subj":"T877","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A878","pred":"mondo_id","subj":"T878","obj":"http://purl.obolibrary.org/obo/MONDO_0011194"},{"id":"A879","pred":"mondo_id","subj":"T879","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A880","pred":"mondo_id","subj":"T880","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A881","pred":"mondo_id","subj":"T881","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Vaccine candidates, like mRNA-1273 SARS-CoV-2 vaccine, INO-4800 DNA coronavirus vaccine, and adenovirus type 5 vector vaccine candidate (Ad5-nCoV), are a few examples under phase I clinical trials, while self-amplifying RNA vaccine, oral recombinant COVID-19 vaccine, BNT162, plant-based COVID-19 vaccine, and Ii-Key peptide COVID-19 vaccine are under preclinical trials (297)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T866","span":{"begin":152,"end":153},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T867","span":{"begin":317,"end":324},"obj":"http://purl.obolibrary.org/obo/PR_000018263"}],"text":"Vaccine candidates, like mRNA-1273 SARS-CoV-2 vaccine, INO-4800 DNA coronavirus vaccine, and adenovirus type 5 vector vaccine candidate (Ad5-nCoV), are a few examples under phase I clinical trials, while self-amplifying RNA vaccine, oral recombinant COVID-19 vaccine, BNT162, plant-based COVID-19 vaccine, and Ii-Key peptide COVID-19 vaccine are under preclinical trials (297)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T27594","span":{"begin":64,"end":67},"obj":"Chemical"},{"id":"T98108","span":{"begin":317,"end":324},"obj":"Chemical"}],"attributes":[{"id":"A2292","pred":"chebi_id","subj":"T27594","obj":"http://purl.obolibrary.org/obo/CHEBI_16991"},{"id":"A82903","pred":"chebi_id","subj":"T98108","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"Vaccine candidates, like mRNA-1273 SARS-CoV-2 vaccine, INO-4800 DNA coronavirus vaccine, and adenovirus type 5 vector vaccine candidate (Ad5-nCoV), are a few examples under phase I clinical trials, while self-amplifying RNA vaccine, oral recombinant COVID-19 vaccine, BNT162, plant-based COVID-19 vaccine, and Ii-Key peptide COVID-19 vaccine are under preclinical trials (297)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T658","span":{"begin":0,"end":377},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Vaccine candidates, like mRNA-1273 SARS-CoV-2 vaccine, INO-4800 DNA coronavirus vaccine, and adenovirus type 5 vector vaccine candidate (Ad5-nCoV), are a few examples under phase I clinical trials, while self-amplifying RNA vaccine, oral recombinant COVID-19 vaccine, BNT162, plant-based COVID-19 vaccine, and Ii-Key peptide COVID-19 vaccine are under preclinical trials (297)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2578","span":{"begin":35,"end":45},"obj":"Species"},{"id":"2579","span":{"begin":68,"end":79},"obj":"Species"},{"id":"2580","span":{"begin":93,"end":110},"obj":"Species"},{"id":"2581","span":{"begin":141,"end":145},"obj":"Species"},{"id":"2586","span":{"begin":250,"end":258},"obj":"Disease"},{"id":"2587","span":{"begin":288,"end":296},"obj":"Disease"},{"id":"2588","span":{"begin":325,"end":333},"obj":"Disease"}],"attributes":[{"id":"A2578","pred":"tao:has_database_id","subj":"2578","obj":"Tax:2697049"},{"id":"A2579","pred":"tao:has_database_id","subj":"2579","obj":"Tax:11118"},{"id":"A2580","pred":"tao:has_database_id","subj":"2580","obj":"Tax:28285"},{"id":"A2581","pred":"tao:has_database_id","subj":"2581","obj":"Tax:2697049"},{"id":"A2586","pred":"tao:has_database_id","subj":"2586","obj":"MESH:C000657245"},{"id":"A2587","pred":"tao:has_database_id","subj":"2587","obj":"MESH:C000657245"},{"id":"A2588","pred":"tao:has_database_id","subj":"2588","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Vaccine candidates, like mRNA-1273 SARS-CoV-2 vaccine, INO-4800 DNA coronavirus vaccine, and adenovirus type 5 vector vaccine candidate (Ad5-nCoV), are a few examples under phase I clinical trials, while self-amplifying RNA vaccine, oral recombinant COVID-19 vaccine, BNT162, plant-based COVID-19 vaccine, and Ii-Key peptide COVID-19 vaccine are under preclinical trials (297)."}